< Back to companies
Mursla
Cambridge, Massachusetts, United States
Novel multi-omics exosome characterisation company enabling the discovery and profiling of exosome phenotypes in diseases. Creating 2nd generation of liquid biopsy tests.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2017
- Website
- mursla.com/
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of Mursla?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now